Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.96    0.72 (2.10%)
Bid:
34.86
Ask:
35.10
Spread: 0.24 (0.688%)
Market Cap: £559.02m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Third Quarter Trading Statement

16 Apr 2026 07:00

RNS Number : 6571A
Hays PLC
16 April 2026
 

 

 

Hays plc

Third Quarter Trading Statement

 

16 April 2026

Hays plc ('Hays' or the 'Company') today announces its quarterly update for the three months ended 31 March 2026 ('Third Quarter Trading Statement'), which is available at: http://www.rns-pdf.londonstockexchange.com/rns/6571A_1-2026-4-15.pdf.

The Third Quarter Trading Statement will also be available on the Hays website www.hays.com/investors and has been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Conference call

James Hilton and Kean Marden will conduct a conference call for analysts and investors at 9:00am UK time on 16 April 2026. Participants are invited to register via the URL link below:

https://register-conf.media-server.com/register/BIb2dccc61ba874c0eb9668de1eee5890d

 

Once registered, you will receive a confirmation email, with the details of the call and a personal login link and PIN which will place you directly into the call, without the need to speak to an operator. The call will be recorded and will also be available for playback via the results centre on our investor website.

 

Enquiries

 

Hays plc

 James Hilton

Chief Financial Officer

+44 (0) 203 978 2520

 Kean Marden

Head of Investor Relations & M&A

+44 (0) 333 010 7092

 

 

FGS Global

 Guy Lamming

hays@fgsglobal.com

 Anjali Unnikrishnan

 Richard Crowley

 

 

LEI: 213800QC8AWD4BO8TH08

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIAMLTMTMBBFF
Date   Source Headline
28th Nov 202412:14 pmRNSDirector/PDMR Shareholding
26th Nov 202411:02 amRNSHolding(s) in Company
20th Nov 20242:27 pmRNSBoard Committee Changes
20th Nov 20242:07 pmRNSResult of AGM
1st Nov 202410:00 amRNSTotal Voting Rights
25th Oct 20242:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20241:49 pmRNSHolding(s) in Company
16th Oct 20242:01 pmRNSHolding(s) in Company
11th Oct 20247:00 amRNSFirst Quarter Trading Statement
10th Oct 20244:44 pmRNSDirector/PDMR Shareholding - Amendment
10th Oct 202412:45 pmRNSDirector/PDMR Shareholding
7th Oct 20243:14 pmRNSDirector/PDMR Shareholding
7th Oct 202412:43 pmRNSAnnual Financial Report
1st Oct 202410:00 amRNSTotal Voting Rights
27th Sep 20242:39 pmRNSDirector/PDMR Shareholding
12th Sep 20243:52 pmRNSDirector/PDMR Shareholding
9th Sep 20242:45 pmRNSDirector/PDMR Shareholding
6th Sep 20242:16 pmRNSDirector/PDMR Shareholding
4th Sep 20244:30 pmRNSDirector/PDMR Shareholding
2nd Sep 202410:27 amRNSTotal Voting Rights
22nd Aug 20247:00 amRNSFinal Results
20th Aug 20245:00 pmRNSCompany Secretary Change
20th Aug 20244:02 pmRNSHolding(s) in Company
1st Aug 202410:15 amRNSBlock listing Interim Review
1st Aug 202410:00 amRNSTotal Voting Rights
11th Jul 20247:00 amRNSFourth Quarter Trading Statement
1st Jul 202410:00 amRNSTotal Voting Rights
6th Jun 20243:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:00 amRNSTotal Voting Rights
3rd May 20242:07 pmRNSResponse to Voting Results
1st May 202410:00 amRNSTotal Voting Rights
16th Apr 20247:00 amRNSThird Quarter Trading Statement
12th Apr 202410:06 amRNSDirector/PDMR Shareholding
9th Apr 202410:22 amRNSHolding(s) in Company
8th Apr 20244:00 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:03 amRNSTotal Voting Rights
28th Mar 202412:20 pmRNSDirector/PDMR Shareholding
20th Mar 20242:40 pmRNSDirector/PDMR Shareholding
1st Mar 202410:00 amRNSTotal Voting Rights
22nd Feb 20247:00 amRNSHalf-year Report
20th Feb 20243:15 pmRNSAppointment of Non-Executive Directors
20th Feb 20243:10 pmRNSBoard and Committee Changes
1st Feb 202411:00 amRNSBlock listing Interim Review
1st Feb 202410:00 amRNSTotal Voting Rights
9th Jan 20247:00 amRNSSecond Quarter Trading Statement
2nd Jan 202410:00 amRNSTotal Voting Rights
13th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 202311:00 amRNSDirector/PDMR Shareholding
1st Dec 20231:00 pmRNSDirector/PDMR Shareholding
1st Dec 202310:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.